CTLA4 and neoplasm: It is probable that our findings of a lack of tumor-infiltrating lymphocytes and the weak IFN-γ signature of MucM are associated with this tumor’s relative resistance to anti–PD-1 and anti–PD-1+anti–CTLA-4 as compared with CM tumors (12).